Development and Function of Natural Autoreactive B Cells
Development and Function of Natural Autoreactive B Cells
批准号:
6472849
负责人:
KYOKO HAYAKAWA
金额:
$18.1万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2007-03-31
中文摘要
描述(由申请人提供):尽管普遍认为B
具有自身反应性的细胞被删除或使其功能失活,
自身反应性抗体,被称为“天然自身抗体”,可以被发现
在健康动物的血清中,与克隆耐受性明显矛盾,
理论VH 36 O 9/VK 21 C编码的抗胸腺细胞/T细胞自身抗体
生殖系基因是这样一种天然抗体,来源于CD 5 + B细胞(B-1),
小鼠,主要负责天然自身抗体的群体
分泌物ATA识别发育调节的T细胞特异性
胸腺细胞上表达的Thy-1/CD 90糖蛋白上的碳水化合物表位,
辅助性T细胞我们先前对VH 36 O 9 mu转基因小鼠(ATAmuTg)的研究
证明ATA B细胞的产生和血清ATA的分泌
需要自身抗原,因为这两者在Thy-1敲除小鼠中均不存在。在
相比之下,ATA特异性的强制表达是由骨髓B细胞引起的,
VH 3609 mu/VK 29 C双转基因小鼠(ATAmuKTg)主要导致
正如我们最近的研究所表明的那样。在这里,我们建议调查
为什么会发生这种正选择和负选择通过表征
VH 36 O 9 mu/VK 29 C双转基因小鼠(ATAmuKTg),我们将鉴定
B细胞阳性/阴性选择的发育阶段(目的1)。到
研究抗原形式是否对阳性/阴性选择至关重要,我们
将建立Thy-1转基因小鼠系,表达跨膜或
分泌型Thy-1(Aim 2)在Aim 3中,我们将测试阳性选择是否是
胎儿“B-1”B细胞发育的独特特征,
自身反应特异性选择差异的可能性
将测试“B-1”与“B-2”B细胞发育之间的阈值(目标3)。
实现这些目标将有助于更全面地了解
抗原受体库的选择在B细胞的发展,并将测试我们的
假设天然自身反应性B细胞生成是先天性免疫缺陷的一部分,
免疫系统“B-1”可主动产生某些自身反应性B细胞
对免疫保护至关重要,保留重要的淋巴细胞克隆,
在免疫监测中发挥作用。
英文摘要
DESCRIPTION (provided by applicant): Although it is widely accepted that B
cells with self-reactivity are deleted or rendered functionally inactive,
self-reactive antibodies, referred to as "natural autoantibodies," can be found
in the serum of healthy animals, in an apparent paradox to the clonal tolerance
theory. An anti-thymocyte/T cell autoantibody (ATA) encoded by VH36O9/VK 21C
germline genes is such a natural antibody, derived from CD5+ B cells (B-1) in
mice, the population predominantly responsible for natural autoantibody
secretion. ATA recognizes a developmentally regulated T cell specific
carbohydrate epitope on the Thy-l/CD90 glycoprotein expressed on thymocytes and
helper T cells. Our previous work with VH36O9mu transgenic mice (ATAmuTg)
demonstrated that the generation of ATA B cells and the secretion of serum ATA
required self-antigen, since both were absent from Thy-1 knockout mice. In
contrast, forced expression of ATA specificity by the bone marrow B cells in
VH36O9mu/VK29C double transgenic mice (ATAmuKTg) results in predominantly
negative selection as our recent study suggests. Here we propose to investigate
why this positive versus negative selection occurs. By characterizing
VH36O9mu/VK29C double transgenic mice (ATAmuKTg), we will identify the
developmental stage(s) of B cell positive/negative selection (Aim 1). To
investigate if the antigen form is critical for positive/negative selection, we
will establish Thy-1 transgenic mouse lines expressing either transmembrane or
secreted Thy-1 (Aim 2) In Aim 3 we will test whether positive selection is a
unique feature of fetal "B-1" B cell development, selecting in favor of natural
autoreactive specificities. The possibility of differences in selection
threshold between "B-1" versus "B-2" B cell development will be tested (Aim 3).
Accomplishing these aims will help to establish a more complete picture of
antigen receptor repertoire selection in B cell development and will test our
hypothesis that natural autoreactive B cell generation is a part of the innate
immune system. "B-1" may actively produce certain autoreactive B cells
essential for immune protection, preserving important lymphocyte clones for the
rest of life to serve in immunologic surveillance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation and characterization of human B1 B cells induced by Lin28b reprogramming of adult hematopoietic progenitors
-
批准号:8991714
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2015
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
-
批准号:8403711
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2009
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
-
批准号:7743435
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2009
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
-
批准号:7990428
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2009
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
-
批准号:8204966
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2009
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
-
批准号:7580562
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2009
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:7877950
-
项目类别:
-
资助金额:$43.19万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:6722840
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:7522676
-
项目类别:
-
资助金额:$43.32万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:8274767
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:8076281
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:6878524
-
项目类别:
-
资助金额:$44.55万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:7033082
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:6624174
-
项目类别:
-
资助金额:$41.99万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:7622155
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2002
-
负责人:KYOKO HAYAKAWA
-
依托单位:
Development and Function of Natural Autoreactive B Cells
-
批准号:6319105
-
项目类别:
-
资助金额:$46.15万
-
财政年份:2001
-
负责人:KYOKO HAYAKAWA
-
依托单位:
DEVELOPMENT & CONTROL OF NATURAL ANTOREACTIVE B T CELL
-
批准号:6373688
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1997
-
负责人:KYOKO HAYAKAWA
-
依托单位:
DEVELOPMENT & CONTROL OF NATURAL ANTOREACTIVE B T CELL
-
批准号:2389334
-
项目类别:
-
资助金额:$21.28万
-
财政年份:1997
-
负责人:KYOKO HAYAKAWA
-
依托单位:
DEVELOPMENT & CONTROL OF NATURAL ANTOREACTIVE B T CELL
-
批准号:2887542
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1997
-
负责人:KYOKO HAYAKAWA
-
依托单位:
DEVELOPMENT & CONTROL OF NATURAL ANTOREACTIVE B T CELL
-
批准号:6170593
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1997
-
负责人:KYOKO HAYAKAWA
-
依托单位:
海外基金